Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study87

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study31

Views

Views
June 20251
July 202513
August 20254
September 20252
October 20252
November 20256
December 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil11
Austria2
Colombia1
Germany1
United Kingdom1
Netherlands1
Peru1
Turkey1
 

Top cities views

Views
Rio de Janeiro2
Vienna2
Ashburn2
Amsterdam1
Ankara1
Brooklyn1
Cabo Frio1
Caxias do Sul1
Cotia1
Hamilton1